OTTONELLI, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 814
EU - Europa 637
AS - Asia 185
SA - Sud America 1
Totale 1.637
Nazione #
US - Stati Uniti d'America 811
IT - Italia 411
GB - Regno Unito 71
HK - Hong Kong 64
SE - Svezia 61
CN - Cina 47
SG - Singapore 26
ID - Indonesia 21
DE - Germania 20
FI - Finlandia 15
FR - Francia 15
BG - Bulgaria 10
LT - Lituania 10
MY - Malesia 9
VN - Vietnam 8
ES - Italia 5
IE - Irlanda 4
BE - Belgio 3
CH - Svizzera 3
PL - Polonia 3
TR - Turchia 3
AN - Antille olandesi 2
GR - Grecia 2
IL - Israele 2
IN - India 2
NL - Olanda 2
TW - Taiwan 2
UA - Ucraina 2
BR - Brasile 1
CA - Canada 1
KR - Corea 1
Totale 1.637
Città #
Chandler 115
Fairfield 109
Ashburn 84
Modena 71
Seattle 63
Hong Kong 62
Woodbridge 59
Nyköping 52
Southend 42
New York 41
Cambridge 39
Houston 37
Wilmington 29
Bologna 24
Chicago 24
Jakarta 21
Reggio Emilia 19
Singapore 18
San Diego 17
Beijing 15
Shanghai 13
Helsinki 12
London 12
Milan 12
Parma 11
Princeton 11
Sofia 10
Ann Arbor 9
Dong Ket 8
Rome 8
Falls Church 7
Sassuolo 6
Cagliari 5
Cento 5
Dearborn 5
Naples 5
Vailate 5
Bari 4
Besano 4
Bomporto 4
Como 4
Des Moines 4
Dublin 4
Eugene 4
Iesi 4
Padova 4
Turin 4
Baricella 3
Brussels 3
Castelcovati 3
Duncan 3
Hounslow 3
Imola 3
Lappeenranta 3
Macchiagodena 3
Minneapolis 3
Munich 3
Nanjing 3
Nocera Inferiore 3
Prato 3
Soliera 3
Washington 3
Aberdare 2
Acton 2
Albairate 2
Alicante 2
Amsterdam 2
Angers 2
Boardman 2
Castelfranco Emilia 2
Castelnovo 2
Central 2
Chieti 2
Chiswick 2
Cividale del Friuli 2
Ferrara 2
Florence 2
Formigine 2
Izmir 2
Jacksonville 2
Maranello 2
Norwalk 2
Osio Sopra 2
Piovene Rocchette 2
Poggiomarino 2
Prescot 2
Ramiola 2
Rende 2
San Giuliano Milanese 2
Steinhausen 2
Traversetolo 2
Trento 2
Tusa 2
Verona 2
Viareggio 2
Willemstad 2
Wuhan 2
Athens 1
Aversa 1
Belo Horizonte 1
Totale 1.243
Nome #
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 210
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 168
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 159
Nanomedicine against Aβ aggregation by β–sheet breaker peptide delivery: In vitro evidence 147
Investigating Novel Syntheses of a Series of Unique Hybrid PLGA-Chitosan Polymers for Potential Therapeutic Delivery Applications 139
Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidence 128
Microfluidic technology for the production of hybrid nanomedicines 97
Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease 88
Tween® preserves enzyme activity and stability in PLGA nanoparticles 76
Optimization of an Injectable Hydrogel Depot System for the Controlled Release of Retinal-Targeted Hybrid Nanoparticles 64
"Combo" Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury 58
Recent Advances on Surface-Modified GBM Targeted Nanoparticles: Targeting Strategies and Surface Characterization 48
Autism-associated SHANK3 mutations impair maturation of neuromuscular junctions and striated muscles 45
Nanotecnologie avanzate per il Sistema Nervoso Centrale: progettazione, ottimizzazione, applicazione, e scale-up 43
Tunneling Nanotubes: A New Target for Nanomedicine? 37
Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington's disease 35
Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments 32
Nanowired Delivery of Curcumin Attenuates Methamphetamine Neurotoxicity and Elevates Levels of Dopamine and Brain-Derived Neurotrophic Factor 23
Enzyme Stability in Nanoparticle Preparations Part 1: Bovine Serum Albumin Improves Enzyme Function 19
Hyaluronic Acid Scaffolds for Loco-Regional Therapy in Nervous System Related Disorders 17
Quantitative comparison of the protein corona of nanoparticles with different matrices 16
Corrigendum to “Quantitative comparison of the protein corona of nanoparticles with different matrices” [Int J Pharm X 2022 Oct 21;4: 100136] (International Journal of Pharmaceutics: X (2022) 4, (S2590156722000251), (10.1016/j.ijpx.2022.100136)) 9
Polymer-lipid hybrid nanomedicines to deliver siRNA in and against glioblastoma cells 8
C-end rule peptide-guided niosomes for prostate cancer cell targeting 7
Strategies for Improved pDNA Loading and Protection Using Cationic and Neutral LNPs with Industrial Scalability Potential Using Microfluidic Technology 5
Totale 1.678
Categoria #
all - tutte 10.986
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.986


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020123 5 3 4 6 6 7 12 14 12 29 13 12
2020/2021378 35 17 32 42 13 22 57 29 21 39 32 39
2021/2022297 20 2 13 23 34 25 18 17 42 28 37 38
2022/2023349 36 37 22 38 30 33 13 39 34 15 24 28
2023/2024480 24 43 34 41 76 53 31 63 14 27 17 57
2024/202536 36 0 0 0 0 0 0 0 0 0 0 0
Totale 1.678